EUCTR2011-005495-42-DK进行中（未招募）不适用
Individualised first line chemotherapy in metastatic colo-rectal cancer (mCRC).Is plasma TIMP-1 a predictive factor for best choise of first line chemotherapy in mCRC? - Individualised choise of 1.line chemotherapy in metastatic colo-rectal cancer
Kell Osterlind0 个研究点目标入组 210 人开始时间: 2012年4月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histologically proven colon or rectal cancer
- •Metastatic disease primary (stage IV) or due to relapse of previous (resected) stage I-III disease
- •At least 1 measurable lesion
- •18 years of age or older
- •WHO performance status <3
- •Expected survival >3 months
- •Hgb>6.1 mmol/L, WBC>2.9, platelets>99
- •Kidney and liver function tests below certain defined upper limits
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 120
排除标准
- •Previous chemotherapy (including adjuvant after primary surgery)
- •Previous cancer (except non melanoma skin cancer)
- •Allergy to any of the therapeutical substances
- •Neuropathy (e.g. alcoholic or diabetic)
- •Recent myocardial infarction or stroke
- •Uncontrollable hypertension
研究者
相似试验
进行中（未招募）
1 期
Sequential first-line therapy in metastatic colorectal cancer with Capecitabine/FUFA, Irinotecan and Bevacizumabmetastatic colorectal cancerMedDRA version: 20.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864EUCTR2009-013099-38-DEKlinikum der Universität München, Anstalt des öffentlichen Rechts vertreten durch den Vorstand450
尚未招募
3 期
A study to see effectiveness of chemotherapy for older patients with lung cancer.CTRI/2022/07/044193Tata Memorial Hospital
进行中（未招募）
不适用
Dosisdichte 1st-line Therapie des metastasierten Mammakarzinoms mit Paclitaxel und liposomalem Doxorubicin (Myocet®)metastasiertes MammakarzinomMedDRA version: 9.1Level: LLTClassification code 10006187Term: Breast cancerEUCTR2005-004234-41-DEOtto-von-Guericke Universität Magdeburg
进行中（未招募）
不适用
Individual Therapy by Gene Expression for Colon Cancer PatientsMetastatic Colon CancerEUCTR2012-001307-20-ESFundación Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO)
进行中（未招募）
不适用
Intensive chemo-immunotherapy as first-line treatment in adult patients with peripheral T-cell Lymphoma PTCL - PTCL intensive chemo-immunotherapyon Hodgkin peripheral T-cell lymphomasMedDRA version: 6.1Level: PTClassification code 10034623EUCTR2006-004234-33-ITISTITUTO NAZIONALE PER LA CURA TUMORI111